BR112019006844A2 - prevenção de alergia - Google Patents
prevenção de alergiaInfo
- Publication number
- BR112019006844A2 BR112019006844A2 BR112019006844A BR112019006844A BR112019006844A2 BR 112019006844 A2 BR112019006844 A2 BR 112019006844A2 BR 112019006844 A BR112019006844 A BR 112019006844A BR 112019006844 A BR112019006844 A BR 112019006844A BR 112019006844 A2 BR112019006844 A2 BR 112019006844A2
- Authority
- BR
- Brazil
- Prior art keywords
- allergy prevention
- allergy
- prevention
- preparation
- natural allergen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Insects & Arthropods (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Abstract
é descrita uma preparação que compreende peptídeos de alérgenos naturais para uso na prevenção de alergia.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16192425 | 2016-10-05 | ||
EP17171268 | 2017-05-16 | ||
PCT/EP2017/075398 WO2018065538A1 (en) | 2016-10-05 | 2017-10-05 | Prevention of allergy |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112019006844A2 true BR112019006844A2 (pt) | 2019-06-25 |
Family
ID=60043193
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112019006844A BR112019006844A2 (pt) | 2016-10-05 | 2017-10-05 | prevenção de alergia |
Country Status (11)
Country | Link |
---|---|
US (1) | US20200222530A1 (pt) |
EP (1) | EP3522921B1 (pt) |
JP (1) | JP2019530702A (pt) |
CN (1) | CN109890414A (pt) |
AU (1) | AU2017341096A1 (pt) |
BR (1) | BR112019006844A2 (pt) |
CA (1) | CA3039101A1 (pt) |
DK (1) | DK3522921T3 (pt) |
ES (1) | ES2868631T3 (pt) |
PL (1) | PL3522921T3 (pt) |
WO (1) | WO2018065538A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10166286B2 (en) | 2015-02-20 | 2019-01-01 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
US11452774B2 (en) | 2015-02-20 | 2022-09-27 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
US10149904B2 (en) | 2015-02-20 | 2018-12-11 | The Board Of Trusteees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
CA3069967A1 (en) | 2017-07-18 | 2019-01-24 | Before Brands, Inc. | Methods for making mixed allergen compositions |
WO2020154476A1 (en) | 2019-01-23 | 2020-07-30 | Before Brands, Inc. | Methods for making mixed allergen compositions |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1247614A (en) | 1969-06-20 | 1971-09-29 | Miles Lab | Improved therapeutic and diagnostic allergenic extract and process for preparing same |
US4822611A (en) | 1986-12-09 | 1989-04-18 | Immunotec, Inc. | Oral hyposensitization in the treatment of allergies |
AU675629B2 (en) | 1992-09-21 | 1997-02-13 | Laboratorios Leti S.A. | A process for the purification of aqueous extracts containing allergenically active proteins, extracts obtainable according to this process as well as their use |
BE1011033A6 (fr) | 1997-03-05 | 1999-04-06 | Univ Bruxelles | Composition pharmaceutique et/ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune ou du cancer. |
JP3790099B2 (ja) | 1997-10-30 | 2006-06-28 | シー・ビー・エフ・レティ・エス・エー | 天然アレルゲンの寛容原性断片 |
EP1872792A1 (en) * | 2006-06-29 | 2008-01-02 | Biotech Tools S.A. | A method for the production of hydrolyzed allergen |
US20100267613A1 (en) | 2007-12-14 | 2010-10-21 | Nestec S.A. | Hypoallergenic cereal protein and uses thereof |
US20100278880A1 (en) * | 2008-01-02 | 2010-11-04 | Biotech Tools S.A. | Pharmaceutical formulation for allergen preparation |
US9066526B2 (en) | 2009-10-16 | 2015-06-30 | Dairy Australia Limited | Allergy treatment using acid treated aqueous whey protein extract |
WO2011150949A1 (en) | 2010-06-04 | 2011-12-08 | N.V. Nutricia | Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins |
EP2436389A1 (en) | 2010-10-01 | 2012-04-04 | Nestec S.A. | Milk-based protein hydrolysates and infant formulae and nutritional compositions made thereof |
AU2012269031B2 (en) | 2011-06-15 | 2016-10-06 | Biotech Tools S.A. | A method for the production of hydrolyzed allergens |
WO2013011095A1 (en) | 2011-07-21 | 2013-01-24 | Biotech Tools S.A. | Dosage of dnak |
JP6419775B2 (ja) * | 2013-03-19 | 2018-11-07 | バイオテック ツールズ エスエー | アレルゲン調製物 |
EP3129001B1 (en) * | 2014-04-10 | 2019-10-02 | ASIT BioTech s.a. | Hsp-free allergen preparation |
WO2016156077A1 (en) | 2015-03-30 | 2016-10-06 | Nestec S.A. | Milk-based protein hydrolysates and compositions made thereof |
-
2017
- 2017-10-05 EP EP17781085.0A patent/EP3522921B1/en not_active Revoked
- 2017-10-05 CN CN201780062259.0A patent/CN109890414A/zh active Pending
- 2017-10-05 JP JP2019518458A patent/JP2019530702A/ja active Pending
- 2017-10-05 ES ES17781085T patent/ES2868631T3/es active Active
- 2017-10-05 WO PCT/EP2017/075398 patent/WO2018065538A1/en active Search and Examination
- 2017-10-05 DK DK17781085.0T patent/DK3522921T3/da active
- 2017-10-05 PL PL17781085T patent/PL3522921T3/pl unknown
- 2017-10-05 BR BR112019006844A patent/BR112019006844A2/pt not_active IP Right Cessation
- 2017-10-05 CA CA3039101A patent/CA3039101A1/en not_active Abandoned
- 2017-10-05 AU AU2017341096A patent/AU2017341096A1/en not_active Abandoned
- 2017-10-05 US US16/338,672 patent/US20200222530A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DK3522921T3 (da) | 2021-03-29 |
CN109890414A (zh) | 2019-06-14 |
PL3522921T3 (pl) | 2021-10-18 |
ES2868631T3 (es) | 2021-10-21 |
EP3522921B1 (en) | 2020-12-23 |
EP3522921A1 (en) | 2019-08-14 |
AU2017341096A1 (en) | 2019-04-04 |
CA3039101A1 (en) | 2018-04-12 |
US20200222530A1 (en) | 2020-07-16 |
JP2019530702A (ja) | 2019-10-24 |
WO2018065538A1 (en) | 2018-04-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112019006844A2 (pt) | prevenção de alergia | |
UY37036A (es) | Compuestos inhibidores de la quinasa de unión a tank | |
BR112019005908A2 (pt) | uso de combinação de anticorpo anti-pd-1 e inibidor de vegfr na preparação de fármaco para tratamento de cânceres | |
CR20160141A (es) | Formulaciones de anticuerpos anti-pdl1 | |
BR112016030968A2 (pt) | análogos de pridopidina, preparação e uso destes | |
BR112017012804A2 (pt) | composições para higiene bucal e métodos de uso. | |
CL2015003507A1 (es) | Beta-caseína a2 y prevención de inflamación del intestino | |
UY36330A (es) | Compuestos inhibidores de quinasa de unión a tank | |
CR20160362A (es) | Anticuerpos anti-jagged1 y metodos de uso | |
BR112018012313A2 (pt) | composições que compreendem 15-hepe e métodos para uso das mesmas | |
CO2019008103A2 (es) | Composiciones farmacéuticas para terapia de combinación | |
CL2014003613S1 (es) | Pedestal para aparato de aseo | |
CL2015002180A1 (es) | Terapia de combinación para el tratamiento de neumonía nosocomial | |
BR112016017402A2 (pt) | fusões anti-pcsk9~glp-1 e métodos para uso | |
BR112017015159A2 (pt) | preparação e uso de produtos plaquetários | |
BR112017012818A2 (pt) | fixador. | |
DOP2017000014A (es) | Métodos para mejorar el rendimiento miocárdico en pacientes con cirugía de fontan que utilizan composiciones de udenafilo | |
DK3226854T3 (da) | Aminosyrebaseret sammensætning til genoprettelse af fibroelastin i hudens bindevæv | |
BR112017002090A2 (pt) | formulação de fator viii | |
CO2017001601A2 (es) | Derivados de 1-acetil-4-((pirazin-2-il) amino)-1,2,3,4-tetrahydroquinolina-6 carboxamida como inhibidores de bromodominio | |
CL2016002779A1 (es) | Composición para el cuidado de la piel | |
BR112015030521A2 (pt) | ferramenta agitadora e uso de uma ferramenta agitadora | |
BR112017011685A2 (pt) | composições compreendendo 15-hepe e métodos de tratamento ou prevenção da fibrose usando as mesmas | |
BR112017008867A2 (pt) | inibidores de proteína quinases | |
BR112016026470A2 (pt) | Composto modulador de hsp70, composição farmacêutica que o compreende e uso do referido composto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2690 DE 26-07-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |